Teva is the first company to produce generic Zemplar (paricalcitol) tablets in the US. The treatment is for patients with Stage 3 or Stage 4 chronic kidney disease and in Stage 5 patients on dialysis.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000882384&fid=1725
Teva launches generic treatment for kidney disease
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.